BCPC vs PATH · P/E 39, rev $240.0M vs P/E 19, rev $1.61B
Balchem Corporation (BCPC) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Balchem Corporation (BCPC) is a specialty chemicals company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported BCPC revenue for 2024-12-31 was $240.0M. Net income was $33.6M. Revenue was up 0.0% from 2024-09-30 to 2024-12-31. BCPC currently screens at market cap $5.38B and trailing P/E 39.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
BCPC currently screens at market cap $5.38B and trailing P/E 39.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the BCPC and PATH stock pages for the full models.
Not investment advice.